cabozantinib
exelixis
['radio', 'cabozantinib']
cabozantinib (c) vs placebo (p) in patients with radioiodine-refractory (rair) differentiated thyroid cancer (dtc) who have progressed after prior vegfr-targeted therapy: outcomes in prespecified subgroups based on prior vegfr-targeted therapy #asco22 
Medicina Interna - Oncología Clínica - Profesor Titular @UPBColombia - Clínica Astorga. #Medellín / #Colombia mlujanonco@gmail.com #OncTwitter #Metaanalysis